Cosmos Health projects over $6 million in annual revenue and $4.3 million in gross profit from the launch of its Oliv18™ supplement across the U.S. cardiovascular health and antioxidant categories.

Cosmos Health has reported strong growth, indicating that its performance remains unaffected by ongoing tensions in the Middle East. This financial update highlights the company's resilience.